Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.5000
+0.0242 (5.09%)
At close: Dec 4, 2025, 4:00 PM EST
0.4859
-0.0041 (-0.84%)
Pre-market: Dec 5, 2025, 4:07 AM EST
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $35.54 million as of December 5, 2025. Its market cap has increased by 523.24% in one year.
Market Cap
35.54M
Enterprise Value
28.19M
1-Year Change
523.24%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $35.54M, a decrease of -72.09%. That is a compound annual growth rate of -29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 34.51M | 234.66% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |